drugs targeting nucleic acids dna & rna · 2oconh 2 nh ome 1.3 alkylating agents 1. drugs...
TRANSCRIPT
© Oxford University Press, 2013
DRUGS TARGETING NUCLEIC ACIDS
DNA & RNA
Patrick: An Introduction to Medicinal Chemistry 5e
Chapter 9
© Oxford University Press, 2013
1. DRUGS ACTING ON DNAIntercalating agentsTopoisomerase poisonsAlkylating agentsMetallating agentsChain cuttersChain terminatorsControl of gene transcription
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.1 Intercalating agents
Mechanism of action• Contain planar aromatic or heteroaromatic ring systems• Planar systems slip between the layers of nucleic acid pairs and disrupt the shape of the helix• Preference is often shown for the minor or major groove• Intercalation prevents replication and transcription • Intercalation can inhibit topoisomerases
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.1 Intercalating agentsExample - Proflavine
Proflavine NH2N NH2
• Planar tricyclic system• The amino substituents are protonated and charged• Used as a topical antibacterial agent in the second world war• Targets bacterial DNA• Too toxic for systemic use
© Oxford University Press, 2013
T A
G C
H3N NH3
O O
proflavine
sugar phosphatebackbone
NH3N NH3
Proflavine
Ionic interactions
T
DNA DOUBLE HELIX
TAG
C
ATC
GCTA
ATCG
AT A
T ATA
TAT A
G CC
T ATA
AG CT
CGCG
ATAT
G
G
1. DRUGS ACTING ON DNA1.1 Intercalating agentsExample - Proflavine
van der Waals interactions
© Oxford University Press, 2013
Extra binding to sugar phosphate backbone by NH3
Doxorubicin (Adriamycin)
OMe
O
O
OH
OH H O
OH
OCH2OH
O
NH3
H
H
H
H
MeH
HOH
O
N
O
NH2
CH3CH3
C C
NH
ONH
CC
D-Val
C
D-Val
L-Pro
N-Me-Gly
L-ProN-Me-Gly
C
O
N-Me-L-ValN-Me-L-Val
C
O
Me MeH H
CO O
H H
O
DactinomycinExtra binding to sugar phosphate
backbone by cyclic peptides
1. DRUGS ACTING ON DNA1.1 Intercalating agents
Examples - anticancer agents
Planar rings
Doxorubicin (Adriamycin)
OMe
O
O
OH
OH H O
OH
OCH2OH
O
NH3
H
H
H
H
MeH
HOH
O
N
O
NH2
CH3CH3
C C
NH
ONH
CC
D-Val
C
D-Val
L-Pro
N-Me-Gly
L-ProN-Me-Gly
C
O
N-Me-L-ValN-Me-L-Val
C
O
Me MeH H
CO O
H H
O
Dactinomycin
Planar rings
Planar rings
Doxorubicin (Adriamycin)
OMe
O
O
OH
OH H O
OH
OCH2OH
O
NH3
H
H
H
H
MeH
HOH
O
N
O
NH2
CH3CH3
C C
NH
ONH
CC
D-Val
C
D-Val
L-Pro
N-Me-Gly
L-ProN-Me-Gly
C
O
N-Me-L-ValN-Me-L-Val
C
O
Me MeH H
CO O
H H
O
Dactinomycin
Planar rings
Planar rings
Doxorubicin (Adriamycin)
OMe
O
O
OH
OH H O
OH
OCH2OH
O
NH3
H
H
H
H
MeH
HOH
O
N
O
NH2
CH3CH3
C C
NH
ONH
CC
D-Val
C
D-Val
L-Pro
N-Me-Gly
L-ProN-Me-Gly
C
O
N-Me-L-ValN-Me-L-Val
C
O
Me MeH H
CO O
H H
O
Dactinomycin
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.1 Intercalating agents
Notes on dactinomycin• Intercalates via minor groove of DNA double helix• Prevents unwinding of DNA double helix• Blocks transcription by blocking DNA-dependent RNA polymerase
Notes on doxorubicin• Intercalates via the major groove of DNA double helix• Blocks the action of topoisomerase II by stabilising the DNA-enzyme complex • Acts as a topoisomerase poison
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.1 Intercalating agentsExamples - Bleomycins
N N
CONH2HN
NH2NH2
O
H2N
Me
O
HNNH
O
Me
HO
MeHN
OHO Me
NH
O
S
N
SN R
O
O
NH
N
O
HO
OH
OH
O
OH
OHO
NH2
O
H
H
H
H
H
H H
H H
OH
Bleomycin A2 R = NHCH2CH2CH2SMe2Bleomycin B2 R = NHCH2CH2CH2CH2NHC(NH2)=NH
imidazolering
pyrimidinering
primary amine
primary amine
primary amide
Bithiazoleintercalatingregion
N N
CONH2HN
NH2NH2
O
H2N
Me
O
HNNH
O
Me
HO
MeHN
OHO Me
NH
O
S
N
SN R
O
O
NH
N
O
HO
OH
OH
O
OH
OHO
NH2
O
H
H
H
H
H
H H
H H
OH
Bleomycin A2 R = NHCH2CH2CH2SMe2Bleomycin B2 R = NHCH2CH2CH2CH2NHC(NH2)=NH
imidazolering
pyrimidinering
primary amine
primary amine
primary amide
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.1 Intercalating agentsNotes on bleomycins• Used as anticancer agents
• Intercalated by means of bithiazole ring system
• Ferrous ion then chelated by nitrogens of the primary amines, amide and pyrimidine ring
• Reaction with oxygen results in a ferric ion and reactive oxygen species
• Results in radical formation and chain cutting
• Bleomycin prevents DNA ligase from repairing damage
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.2 Topoisomerase poisons - non-intercalating
Examples
OO
O
O
MeO
OH
OMe
O
OOOHO
Me
H
HO
4'
4
EtoposideO
O
O
O
MeO
OH
OMe
O
OOOHO
H
HO
4'
4
S
Teniposide
Notes on etoposide and teniposide• Stabilise the complex between DNA and topoisomerase enzymes• Used as anticancer agents• Also cause chain cutting
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.2 Topoisomerase poisons - non-intercalating
Examples - Camptothecin
Notes• Stabilises complex between DNA and topoisomerase I• Single-strand breaks accumulate in the chain• Irreversible double-strand breaks occur during transcription• Semi-synthetic analogues used as anticancer agents
N
N
O
O
OHO
A B CD
E Lactone ring
Me
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.2 Topoisomerase poisons - non-intercalating
Examples - Quinolones and fluoroquinilones
Notes• Synthetic agents used as antibacterial agents• Stabilise complex between bacterial DNA and topoisomerases• Binding site for agents revealed once DNA strands are ‘nicked’
N N
O
CH2CH3
CO2H
Me
Nalidixic acid
N
CO2H
N
O
HN
F
Ciprofloxacin
© Oxford University Press, 2013
1. DRUGS ACTING ON DNA1.2 Topoisomerase poisons - non-intercalating
Examples - Quinolones and fluoroquinilones
Fluoroquinolones
Topoisomeraseenzyme
• Four drug molecules are stacked in the bound complex• Bound to DNA and enzyme by hydrogen and ionic bonds
X8 N
R6
R7
R5 O
O
O
R1
Region binding to DNA
Stacking domain
X8 N
R6
R7
R5 O
O
O
R1
Region binding to enzymeRegion
binding to enzyme
X8 N
R6
R7
R5 O
O
O
R1X8 N
R6
R7
R5 O
O
O
R1
Region binding to enzymeRegion
binding to enzyme
X8 N
R6
R7
R5 O
O
O
R1
© Oxford University Press, 2013
1.3 Alkylating agents
Notes• Contain highly electrophilic groups• Form covalent bonds to nucleophilic groups in DNA
(e.g. 7-N of guanine)• Prevent replication and transcription• Useful anticancer agents• Toxic side effects (e.g. alkylation of proteins)• Can cause interstrand and intrastrand crosslinking if two electrophilic groups present• Alkylation of nucleic acid bases can result in miscoding
1. DRUGS ACTING ON DNA
© Oxford University Press, 2013
Interstrand crosslinkingIntrastrand crosslinking
Crosslinking
NuNu Nu
Nu
1.3 Alkylating agents1. DRUGS ACTING ON DNA
X X
NuNu
X X
Nu
Nu
© Oxford University Press, 2013
1.3 Alkylating agents
Nucleophilic groups on nucleic acid bases
1. DRUGS ACTING ON DNA
nucleophilicgroups
nucleophilicgroups
NH2
N
N
N
N
1
3
R
H2N
HN
N N
N
O7
R
NH2
N
NR
O
3
CytosineGuanineAdenine
© Oxford University Press, 2013
Cytosine Guanine
NN
NH2
OR
HNN
N
NO
H2N
R
Normal base pairing
1.3 Alkylating agents
Thymine Alkylated guanine
NNH
O
O
Me
R
NN
N
NHO
R
H2N
DRUG
Miscoding resulting from alkylated nucleic acid bases
1. DRUGS ACTING ON DNA
Guanine prefers keto tautomer!
Abnormal base pairing.!Alkylated guanine prefers
enol tautomer!
© Oxford University Press, 2013
1.3 Alkylating agents
ExampleChlormethine (nitrogen mustard)
1. DRUGS ACTING ON DNA
Notes• Used medicinally in 1942• Causes intrastrand and interstrand cross-linking• Prevents replication• Mono-alkylation of guanine also possible• Analogues with better properties have been prepared
Me N
Cl
Cl
© Oxford University Press, 2013
Mechlorethamine
H3C N
Cl
Cl Cl
NH3C
Aziridine ion
G = Guanine
DNA
G
N
HN
NN
N
N NH
N
O
O
NH2
NH2
G
DNA
N
N
N
NN
HN
NH
N
O
NH2
O NH2
H3C N
Cl
DNA
NN
N
N NH
N
O
NH2
N
HNO NH2
NH3C
DNA
CH3
N
N
N
N
N
N
HN
NH
N
O NH2
O
NH2
Crosslinked DNA
Mechanism of action
Alkylating agentsChlormethine
© Oxford University Press, 2013
Cl
N2 + HO
Alkylatingagent
ClN N
N
O
O
R
H
1.3 Alkylating agentsExample - Nitrosoureas
1. DRUGS ACTING ON DNA
MechanismDecompose in body to form an alkylating agent and a carbamoylating agent
O
N NH
NO
Cl Cl
Carmustine
O
N NH
NO
Cl
Lomustine
O C N R
ClN
NOH
+
Isocyanate(carbamoylating agent)
H O
arrow
Cl
N2 + HO
Alkylatingagent
© Oxford University Press, 2013
Cl DNA X Y
Cl
X YCross-linking
DNA DNA
AlkylationAlkylatingagent
1.3 Alkylating agentsExample - Nitrosoureas
1. DRUGS ACTING ON DNA
Notes• Alkylating agent causes interstrand crosslinking• Crosslinking between G-G or G-C• Carbamoylating agent reacts with lysine residues on proteins• May inactivate DNA repair enzymes
O C N RIsocyanate
Protein-Lys-NH2Protein-Lys-NH
O
HN RCarbamoylation
© Oxford University Press, 2013
1.3 Alkylating agents1. DRUGS ACTING ON DNA
Synthetic agent used as anticancer agentCauses interstrand crosslinking
Busulfan
OO
SMe
OO
SMe
OO
Mechanism
OO
SMe
OO
SMe
OO
HN
N N
N
O
H2N
Guanine
DNA
-MeSO3-
N
N
DNA
N
N
DNA
N
N
DNA
N
N
DNA
-MeSO3-
OSO2Me
© Oxford University Press, 2013
Notes• Neutral inactive molecule acting as a prodrug• Platinum covalently linked to chloro substituents• Ammonia molecules act as ligands• Activated in cells with low chloride ion concentration• Chloro substituents replaced with neutral water ligands• Produces positively charged species
1.4 Metallating agents1. DRUGS ACTING ON DNA
PtNH3Cl
NH3ClCisplatin
PtNH3Cl
NH3Cl
H2OPt
NH3H2O
NH3ClPt
NH3H2O
NH3H2O
+ 2+
+DNA Pt
NH3DNA
NH3DNACisplatin
© Oxford University Press, 2013
Notes
1.4 Metallating agents1. DRUGS ACTING ON DNA
PtNH3Cl
NH3ClCisplatin
• Binds to DNA in regions rich in guanine units • Intrastrand links rather than interstrand• Localised unwinding of DNA double helix• Inhibits transcription
© Oxford University Press, 2013
1.3 Alkylating agents1. DRUGS ACTING ON DNA
Mechanism
• Prodrug activated by demethylation in liver• Decomposes to form a methyldiazonium ion• Alkylates guanine groups
HN N
CONH2NNNH3CCH3
Cyt P-450
liver
HN N
CONH2NNN
CH3OHH
HN N
CONH2NHNNCH3
-CH2O
H
HN N
CONH2H2N
N N CH3
AIC
Methyldiazonium ion
N2 + CH3
HN N
CONH2NNNH3CCH3
Dacarbazine
© Oxford University Press, 2013
O
O
N
H2N
Me
CH2OCONH2
NH
OMe
1.3 Alkylating agents1. DRUGS ACTING ON DNA
Example - Mitomycin C
Notes• Prodrug activated in the body to form an alkylating agent• One of the most toxic anticancer drugs in clinical use
© Oxford University Press, 2013
OH
OH
N
H2N
Me
CH2
NH2
NH
NH
HN
N N
NO
HN
N N
NO Guanine
Guanine
H2N-DNA
O
O
N
H2N
Me
CH2OCONH2
NH
OMe
O
OH
N
H2N
Me
CH2OCONH2
NH
H
-MeOH
O
OH
N
H2N
Me
CH2OCONH2
NH2
Ring opening
-H +
Alkylating agent
OH
OH
N
H2N
Me
CH2
NH2
NH-DNA
NH-DNA
-CO2 -NH3
Crosslinked DNA
OH
OH
N
H2N
Me
CH2OCONH2
NH
OMe
Reduction
OH
OH
N
H2N
Me
CH2
NH2
NH-DNA
OC
O
NH2
H2N-DNA
H
H
H
© Oxford University Press, 2013
• Intercalating agent• Abstracts H from DNA to generate radicals• Radicals react with oxygen resulting in chain cutting• Bleomycin also inhibits repair enzymes
BLEOMYCIN A2 R = NHCH2CH2CH2SMe2BLEOMYCIN B2 R = NHCH2CH2CH2CH2NHC(NH2)=NH
BleomycinUsed vs skin cancer
N N
NH
NH2CONH2NH2
H2N
CH3 HN
O
NH
O HO
CH3
CH3
OCH3HO
HN
NH N
S
S
N
O
ONH
N
O
HO
OH
OH
OH
OH
OHO
O NH2
O
ROO
1.5 Chain cutters1. DRUGS ACTING ON DNA
© Oxford University Press, 2013
• Generates DNA diradical• DNA diradical reacts with oxygen• Results in chain cutting
1.5 Chain cutters1. DRUGS ACTING ON DNA
OOMe
ICH3
O
OHMeOHOH3C
OMe
S
O
OH3C
OH
O NH
OH3C
HOO
O
MeO
HN
H3C
HS
SS
H3C
HOO
NHCO2Me
Calicheamicin γ1I
Antitumour agent Enediyne system
© Oxford University Press, 2013
RS
HO O
NHCO2Me
SMeS
Nu
RS
HOO
NHCO2Me
Cycloaromatisation!
RS
HOO
NHCO2Me
O2!
Oxidative!cleavage!
DNA DNA(Diradical)
RS
HOO
H
HNHCO2Me
Michael!addition!
RS
HO O
NHCO2Me
1.5 Chain cutters1. DRUGS ACTING ON DNA
Mechanism
H
© Oxford University Press, 2013
Notes:• Azidothymidine is a prodrug used in the treatment of HIV• AZT is phosphorylated to a triphosphate in the body• Triphosphate has two mechanisms of action
- inhibits a viral enzyme (reverse transcriptase)- is added to growing DNA chain and acts as chain terminator
Azidothymidine (AZT) (Zidovudine;Retrovir) HN
N
OCH3
O
OHO
N3
HN
N
OCH3
O
OO
N3
PO
OHOP
O
OHOP
O
OHHO
1.6 Chain terminators1. DRUGS ACTING ON DNA
Chain terminating group
HN
N
OCH3
O
OO
N3
PO
OHOP
O
OHOP
O
OHHO
© Oxford University Press, 2013
HN
N
O
H2N N
N
OHO
Aciclovir(Zovirax)
Notes:• Prodrugs used as antiviral agents• Same mechanisms of action as AZT• Used vs herpes simplex and shingles
Famciclovir(Famvir)
N
NN
N NH2AcO
OAc
1.6 Chain terminators1. DRUGS ACTING ON DNA
Chainterminating group
HN
N
O
H2N N
N
OHO
Chainterminating group
N
NN
N NH2AcO
OAc
© Oxford University Press, 2013
1.6 Chain terminators1. DRUGS ACTING ON DNA
a) Normal replication
PGP P
ATCGAACC
TAG OH3'
DNA template Growing
chain
A
T
C
G
A
A
C
C
T
A OH3'
DNA template
Growingchain
© Oxford University Press, 2013
PDrug
P P
1.6 Chain terminators1. DRUGS ACTING ON DNA
b) Chain termination
A
T
C
G
A
A
C
C
T
A OH3'
DNA template
Growingchain
ATCGAACC
TA
Drug H3'
DNA template Growing
chain
Chain termination
© Oxford University Press, 2013
1.7 Control of gene transcription1. DRUGS ACTING ON DNA
Notes:• Design of synthetic molecules capable of controlling gene transcription• Molecules capable of recognising and binding to specific base pairs• Hairpin polyamides containing heterocyclic rings are capable of binding to the minor groove• Binding involves amide groups and heterocycles• Particular patterns of heterocyclic rings allow recognition of perticular base pairs• Capable of inhibiting transcription• Designed to bind to regulatory element of a gene
© Oxford University Press, 2013
A
C
A
T
G
T
T
G
T
A
C
A
5'3'
1. DRUGS ACTING ON DNA
OO
NH
NN Me
NO
H
NMe
O
ONH
N
N
NH
O
Me
ONH
N
O
H
NMe
MeH
Me
NMe
N HO
N OMe
N H
O
NN
Me
H
N
NMe
O
N
H
H
H
Py
Im
Hp
Py
Py
Py
Hp
Im
Linker
ArmArm
© Oxford University Press, 2013
2. DRUGS ACTING ON rRNAAntibiotics
O2NCH2OH
HO
HN
H
H
CO CHCl2
Chloramphenicol(vs typhoid)
R
Me
O
HNMe
MeOH
O
OHOH
OHO
MeO
O
C
Me Me
OMe O MeMe
OH
H
H
H
H
H
H
H
H
Rifamycins
Streptomycin
H2N C
NH
NH
O
HN C
NH
NH2
O
OO
H
OHH HO
HH
OHH
H
CHO
OH
H
Me
CH2OH
HHO
H
OH
H
H
MeHNH
H
OOHOOH
Cl
OH
NMe2
O
HO
NH2
Me H
OH
Chlortetracycline(Aureomycin)
HO
O
O
O
H3C
CH3
CH3
O
CH3
CH3
HO
H3C
OO
O
CH3
CH3
Me
NMe2
HO
OHOMe
Erythromycin
© Oxford University Press, 2013
Antisense Therapy
Protein synthesis!
3. DRUGS ACTING ON mRNA
m-RNA
antisense molecule
U C A G A U G C A A
A G U C U A C G U U
AAUG A A G Um-RNA
antisensemolecule
© Oxford University Press, 2013
Advantages• Same effect as an enzyme inhibitor or receptor antagonist• Highly specific where the oligonucleotide is 17 nucleotides or more• Smaller dose levels required compared to inhibitors or antagonists• Potentially less side effectsDisadvantages• ‘Exposed’ sections of mRNA must be targeted• Instability and polarity of oligonucleotides (pharmacokinetics)• Short lifetime of oligonucleotides and poor absorption across cell membranes
Antisense Therapy
3. DRUGS ACTING ON mRNA
© Oxford University Press, 2013
• Short segments of double stranded RNA• Recognised by enzyme complex RISC to produce single stranded RNA - small interfering or small inhibitory RNA (siRNA)• Binds to complementary region of mRNA• mRNA is cleaved by enzyme complex
Micro-RNA (miRNA)
3. DRUGS ACTING ON mRNA
RISC
miRNA
RISC
miRNA
RI SC
siRNA
RISC
mRNA
© Oxford University Press, 2013
Advantages• siRNAs have potential to be used in gene therapy• Greater efficiency in silencing mRNA than conventional antisense therapy• One siRNA could lead to cleavage of several mRNA molecules
Micro-RNA (miRNA)
3. DRUGS ACTING ON mRNA
Problems• siRNAs need to be metabolically stable • Need to reach target cells• Need to enter target cells